Transdermal Delivery of Antigenic Protein Using Ionic Liquid-Based Nanocarriers for Tumor Immunotherapy.
antigenic protein
cancer immunotherapy
lipid-based ionic liquid
nanocarrier
transdermal drug delivery
Journal
ACS applied bio materials
ISSN: 2576-6422
Titre abrégé: ACS Appl Bio Mater
Pays: United States
ID NLM: 101729147
Informations de publication
Date de publication:
20 06 2022
20 06 2022
Historique:
pubmed:
27
4
2022
medline:
23
6
2022
entrez:
26
4
2022
Statut:
ppublish
Résumé
Transdermal drug delivery systems (TDDSs) may be useful for preventing various diseases including cancer. However, the stratum corneum (SC) inhibits the permeation of foreign particles into the skin. To obtain an effective TDDS, we developed a protein-containing nanocarrier (PCNC) comprising an antigenic protein (ovalbumin/OVA) stabilized by a combination of surfactants, i.e., a lipid-based surface-active ionic liquid and Tween-80. The PCNC was lyophilized to remove water and cyclohexane and then dispersed in isopropyl myristate. It is biocompatible both
Identifiants
pubmed: 35472266
doi: 10.1021/acsabm.2c00061
doi:
Substances chimiques
Ionic Liquids
0
Proteins
0
Water
059QF0KO0R
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM